From: Gross, Mary Sent: Friday, August 09, 2002 12:40 PM To: Butler, Jennie C Subject: FW: FDA Public Meeting -- Barcoding Human Drugs and Biologics -----Original Message----- From: Kasey Thompson [mailto:kthompson@ashp.org] Sent: Wednesday, July 03, 2002 4:09 PM To: Gross, Mary Cc: Gary Stein; Douglas Scheckelhoff Subject: Re: FDA Public Meeting -- Barcoding Human Drugs and Biologics Hello Mary: Thank you for inviting the American Society of Health-System Pharmacists to participate on the health professional panel. We enthusiastically accept the invitation. I will be the designated individual from our organization on the panel. My detailed contact information is provided below. Please feel free to contact me directly if you have any questions. We will have our written summary to you by July 12. Have a nice 4th of July. Sincerely, Kasey K. Thompson, Pharm.D. Director, Center on Patient Safety American Society of Health-System Pharmacists 7272 Wisconsin Avenue Bethesda, MD 20814 tel: 301-657-3000 X 1270 fax: 301-664-8862 web: http://www.ashp.org/ e-mail: kthompson@ashp.org "Gross, Mary" , "'rgallalgher@ana.org'" , "'kthompson@ashp.org'" 07/03/02 03:48 PM , "'agoldham@phrma.org'" , "'joseph_cranston@ama-assn.org'" , "'spritore@barrlabs.com'" , "'joe_pleasant@premierinc.com'" , "'dspitzenagle@HLC.org'" , "'karen@aabb.org'" , "'tcammack@advamed.org'" , "'WSoller@chpa-info.org'" cc: "Phillips, Jerry" , "Seligman, Paul" Subject: FDA Public Meeting -- Barcoding Human Drugs and Biologics Good afternoon: FDA is holding a public meeting on July 26 at Natcher Auditorium in Bethesda Maryland to discuss current regulatory activity relating to barcoding human drugs and biologics. Your organizations have been identified as having expertise and interest in the development of this regulation. Part of this discussion will be arranged as panel discussions and your groups have been designated as appropriate to participate on either a health professional or industry panel. I am including two attachments, one is a letter explaining the content and logistics of the public meeting and the other is the meeting notice that published in the Federal Register on June 18. This FR notice articulates a number of questions where FDA is seeking specific feedback. We hope you will be able to join us for the meeting. If your group would like to participate, please identify who will be representing your group. Please remember that a written summary of presentations is due to the agency by July 12. Thanks and happy July 4! Mary <> <> (See attached file: barcoding-colleague invite.doc)(See attached file: barcodefr.doc)